UK hospital trials new coronavirus treatment drug

A new drug developed by UK scientists to treat coronavirus patients is being trialled at University Hospital Southampton.

The drug uses a protein called interferon beta, which our bodies produce when we get a viral infection. Interferon beta, which is commonly used in the treatment of multiple sclerosis, is part of the body's first line of defence against viruses, warning it to expect a viral attack. Initial results from the trial are expected by the end of June.

The drug is a special formulation of interferon beta delivered directly to the airways when the virus is there, with the hope that a direct dose of the protein will trigger a stronger anti-viral response even in patients whose immune systems are already weak.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho